ITEOS THERAPEUTICS INC shareholders Q2 2023

ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 146 filers reported holding ITEOS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.

ITEOS THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
VOYA INVESTMENT MANAGEMENT LLC 21,775$288,3010.00%
Tower Research Capital LLC (TRC) 987$13,0680.00%
JANE STREET GROUP, LLC 61,135$809,4280.00%
Zurcher Kantonalbank (Zurich Cantonalbank) 5,758$76,2360.00%
FEDERATED HERMES, INC. 2,376$31,4580.00%
Swiss National Bank 50,600$669,9440.00%
Mirae Asset Global Investments Co., Ltd. 14,004$185,5320.00%
Allworth Financial LP 21$2790.00%
ROYAL BANK OF CANADA 2,586$34,0000.00%
Lindbrook Capital, LLC 77$1,0190.00%
25 LLC 34$4730.00%
JPMORGAN CHASE & CO 20,448$270,7320.00%
KBC Group NV 1,773$230.00%
Nuveen Asset Management, LLC 75,711$1,002,4140.00%
Citadel Advisors 2,300$30,4520.00%
Citadel Advisors 18,100$239,6440.00%
Covestor Ltd 4$00.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 10,296$136,3190.00%
GROUP ONE TRADING, L.P. 7,321$96,9300.00%
Legal & General Group Plc 63,892$845,9310.00%
External links

This page lists ITEOS THERAPEUTICS INC's shareholders in Q2 2023. To view ITEOS THERAPEUTICS INC's shareholder history, click here.